Literature DB >> 9276427

Use of the isolator 1.5 microbial tube for culture of synovial fluid from patients with septic arthritis.

P Yagupsky1, J Press.   

Abstract

Synovial fluid specimens obtained from patients with arthritis were plated onto solid media (conventional cultures) or inoculated into an Isolator 1.5 microbial tube (Isolator cultures), and the yield and time to detection of organisms were compared. Overall, 144 specimens obtained from 137 patients were processed, and 31 (21.5%) cultures obtained from 29 patients were positive by at least one method. Staphylococcus aureus was isolated from 12 patients, Streptococcus pneumoniae and Kingella kingae were isolated from 4 patients each, group G streptococci were isolated from 3 patients, Staphylococcus epidermidis and members of the family Enterobacteriaceae were isolated from 2 patients each, and Streptococcus mitis and Peptostreptococcus prevotii were isolated from 1 patient each. Overall, the causative organism was detected in 31 of 31 (100.0%) Isolator cultures and 24 of 31 (77.4%) conventional cultures (P < 0.02). Twenty-nine of 31 (93.5%) positive Isolator cultures and 20 of 24 (83.3%) conventional cultures were positive by the second day of incubation. Among the 24 cultures positive by both methods, higher numbers of CFU per milliliter were detected with the Isolator system in 13 cultures and with conventional cultures in 2 cultures (P < 0.002). Inoculation of synovial fluid into an Isolator 1.5 microbial tube improves the recovery of organisms causing septic arthritis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9276427      PMCID: PMC229979          DOI: 10.1128/jcm.35.9.2410-2412.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

Review 1.  Blood cultures: issues and controversies.

Authors:  J A Washington; D M Ilstrup
Journal:  Rev Infect Dis       Date:  1986 Sep-Oct

2.  Evaluation of a lysis-centrifugation system for recovery of yeasts and filamentous fungi from blood.

Authors:  J Bille; L Stockman; G D Roberts; C D Horstmeier; D M Ilstrup
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

Review 3.  Clinical issues of blood cultures.

Authors:  P H Chandrasekar; W J Brown
Journal:  Arch Intern Med       Date:  1994-04-25

Review 4.  Bacterial arthritis.

Authors:  D L Goldenberg; J I Reed
Journal:  N Engl J Med       Date:  1985-03-21       Impact factor: 91.245

5.  The differential diagnosis of benign and septic joint disease in children. Clinical, radiologic, laboratory, and joint fluid analysis, based on 37 children with septic arthritis and 97 with benign aseptic arthritis.

Authors:  R A Molteni
Journal:  Clin Pediatr (Phila)       Date:  1978-01       Impact factor: 1.168

6.  Clinical comparison of the Isolator 1.5 microbial tube and the BACTEC radiometric system for detection of bacteremia in children.

Authors:  R B Carey
Journal:  J Clin Microbiol       Date:  1984-05       Impact factor: 5.948

7.  Acute infectious arthritis. A review of patients with nongonococcal joint infections (with emphasis on therapy and prognosis).

Authors:  D L Goldenberg; A S Cohen
Journal:  Am J Med       Date:  1976-03       Impact factor: 4.965

8.  Use of lysis-centrifugation (isolator) and radiometric (BACTEC) blood culture systems for the detection of mycobacteremia.

Authors:  V J Gill; C H Park; F Stock; L L Gosey; F G Witebsky; H Masur
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

9.  Pyogenic arthritis in infants and children: a review of 95 cases.

Authors:  C J Welkon; S S Long; M C Fisher; P D Alburger
Journal:  Pediatr Infect Dis       Date:  1986 Nov-Dec

10.  Septic arthritis and osteomyelitis in children.

Authors:  C W Fink; J D Nelson
Journal:  Clin Rheum Dis       Date:  1986-08
View more
  10 in total

1.  Use of BACTEC 9240 blood culture system for detection of Brucella melitensis in synovial fluid.

Authors:  P Yagupsky; N Peled; J Press
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Use of blood culture systems for isolation of Kingella kingae from synovial fluid.

Authors:  P Yagupsky
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

3.  Recovery of Kingella kingae from blood and synovial fluid of two pediatric patients by using the BacT/Alert system.

Authors:  F Lejbkowicz; L Cohn; N Hashman; I Kassis
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

4.  Culture with BACTEC Peds Plus/F bottle compared with conventional methods for detection of bacteria in synovial fluid.

Authors:  J G Hughes; E A Vetter; R Patel; C D Schleck; S Harmsen; L T Turgeant; F R Cockerill
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  Use of the Isolator 1.5 microbial tube for detection of Brucella melitensis in synovial fluid.

Authors:  Pablo Yagupsky; Nechama Peled
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

Review 6.  Management of septic arthritis: a systematic review.

Authors:  C J Mathews; G Kingsley; M Field; A Jones; V C Weston; M Phillips; D Walker; G Coakley
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

Review 7.  Kingella kingae: carriage, transmission, and disease.

Authors:  Pablo Yagupsky
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

8.  Current trends of microorganisms and their sensitivity pattern in paediatric septic arthritis: A prospective study from tertiary care level hospital.

Authors:  Girish Motwani; Rujuta Mehta; Alaric Aroojis; Sandeep Vaidya
Journal:  J Clin Orthop Trauma       Date:  2016-09-28

9.  Septic arthritis: patients with or without isolated infectious agents have similar characteristics.

Authors:  J Madruga Dias; M M Costa; J A Pereira da Silva; M Viana de Queiroz
Journal:  Infection       Date:  2013-12-07       Impact factor: 3.553

10.  Septic arthritis in the native joint.

Authors:  Meghan B Brennan; Jennifer L Hsu
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.